The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Explore ways to utilize your free time for side jobs. These practical suggestions can help you earn more without overwhelming your schedule.
23,951 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A real estate liquidity squeeze is unfolding as investors pull billions from property funds. Could this be the first ...
As the 2026 earnings season unfolds, investors want real, actionable insights on fidus (FDUS) 2026 earnings. This ana...
A high-profile clash between the Pentagon and a leading AI firm hits markets and wallets. Regulators, investors, and ...
The EEOC plans to end federal demographics collection used to monitor workplace bias, a shift that could alter how di...
A fresh look at retirement rules shows social security’s hidden formula reduces replacement rates for high earners, u...
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Public blunders can impact more than pride—they can touch endorsements, streaming dollars, and future opportunities. ...
Long-dated Treasuries extended a six-year losing streak in 2025. A new, low-profile ETF is engineered to profit if ra...
Celebrity moments on luxury yachts captivate fans and investors alike. This article dissects the financial impact of ...
A large required minimum distribution can push high earners into higher Medicare surcharge brackets. Here's how it wo...
July can be a pivotal moment for travel stocks. Here are three clear reasons why Carnival stock may deserve a place o...